Medline looking for a buyer, could fetch as much as $30B, Wall Street Journal says

Medline is exploring a sale that could value the company at as much as $30 billion, The Wall Street Journal reported. 

Advertisement

The Northfield, Ill.-based supply company has hired Goldman Sachs Group to run the process of finding potential buyers, people familiar with the matter told the Journal. There’s no guarantee the company will be sold. The sources told the Journal an IPO or minority investment is also a possibility. 

Medline is likely to attract private equity bidders, and Blackstone Group, KKR and Carlyle Group are among those expected to consider bids, according to the Journal. 

Medline makes and distributes medical supplies used in hospitals, surgery centers, acute care facilities and other healthcare facilities in more than 125 countries. It has $17.5 billion in annual sales, the Journal reported. 

Read the full article here. 

More articles on supply chain:
51 best hospital, health system supply chains in North America, per GHX
Shortage of plastic growbags threatens global vaccine supply
Intermountain signs 10-year contract with Vizient

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.